The study will evaluate if an investigational RSV (respiratory syncytial virus) vaccine administered to pregnant women can prevent respiratory tract illnesses associated with RSV in their babies after birth. RSV is a common respiratory virus that usually causes mild, cold-like symptoms for most people, but can be dangerous for some infants and young children. 

TrialSearch is the best way to search for and match with clinical trials recruiting in your area.

Terms of Use   Privacy Policy
© 2021 TrialSearch / All rights reserved.

Clinical Trial Safety

57,000

100-500

yearly deaths in children under 5 years old due to RSV1

1.5 million

children are

hospitalized due

to RSV infection1

When performing clinical trials, researchers put the safety of the participants above all else. The maternal RSV studies enrolling now are Phase 3 trials, meaning the initial stage of testing is complete, and the vaccine has been determined as safe to expand to a larger population.

All studies we connect you with are FDA-authorized and thoroughly evaluated against ethical and safety standards. Through every phase of the process, studies seek approval from regulating entities, follow highly protective policies, and acquire informed consent from all the study volunteers. 

RSV vaccine clinical studies enrolling pregnant women 
(2nd and 3rd trimesters)

About TrialSearch

TrialSearch is your source for hundreds of actively enrolling clinical trials – giving you what you want most – choices to find the trial that’s the best fit for you. And we’re adding new studies all the time. Once you express interest, our medically trained support team will help you understand which trials you may qualify for, all while answering any questions you have along the way.

We work directly with the doctors, clinics and hospitals running the trials, so we always have up-to-date information on the qualification criteria, active locations and enrollment status of every trial in our system, updated in real time.

1-844-915-1364

You can earn up to $1,000 for participating

See If You're Eligible

1 Annually in the United States. Source: CDC

  • Receive the study vaccine in your second or third trimester 
  • Attend periodic follow-up visits at the study site 
  • Provide updates over the phone 
  • Researchers will track your baby’s health for up to 6 months after birth 
  • Receive up to $1,000 for your participation (depending on location) 

If you decide to participate in the study, you will:

You can help advance the first RSV vaccine

As there are currently no licensed RSV vaccines available to prevent infection, clinical trials are underway.

See If You Qualify

outpatient pediatric visits are attributed to RSV infections1

Take the Pre-Screener